Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (563)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
988
Price
$538.51
Total Value
$532.04K
Shares Held After
48,397
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
518
Price
$537.75
Total Value
$278.55K
Shares Held After
49,385
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
110
Price
$536.28
Total Value
$58.99K
Shares Held After
49,903
% of Holdings
0.2%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
2,436
Price
$1.93
Total Value
$4.70K
Shares Held After
14,394
% of Holdings
16.9%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,000
Price
$43.15
Total Value
$43.15K
Shares Held After
149,914
% of Holdings
0.7%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,308
Price
$42.17
Total Value
$139.51K
Shares Held After
150,914
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,792
Price
$41.39
Total Value
$156.96K
Shares Held After
154,222
% of Holdings
2.4%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,900
Price
$40.09
Total Value
$76.17K
Shares Held After
158,014
% of Holdings
1.2%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
135,590
Price
$28.97
Total Value
$3.93M
Shares Held After
7,751,570
% of Holdings
1.7%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
488,654
Price
$28.35
Total Value
$13.85M
Shares Held After
7,887,160
% of Holdings
5.8%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
2,531
Price
$1.93
Total Value
$4.88K
Shares Held After
21,729
% of Holdings
11.6%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
3,277
Price
$1.93
Total Value
$6.32K
Shares Held After
16,689
% of Holdings
19.6%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
20,216
Price
$25.19
Total Value
$509.18K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
7,026
Price
$18.53
Total Value
$130.22K
Shares Held After
1,203,784
% of Holdings
0.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
2,106
Price
$1.93
Total Value
$4.06K
Shares Held After
13,113
% of Holdings
16.1%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
8,543
Price
$4.26
Total Value
$36.43K
Shares Held After
167,750
% of Holdings
4.8%
Nuvectis Pharma, Inc. (NVCT)
Mosseri Marlio Charles — 10% Owner
Shares
50,000
Price
$18.32
Total Value
$916.00K
Shares Held After
3,186,576
% of Holdings
1.6%
Nuvectis Pharma, Inc. (NVCT)
BENTSUR RON — Director
Shares
12,500
Price
$20.00
Total Value
$250.00K
Shares Held After
3,688,424
% of Holdings
0.3%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
20,000
Price
$12.00
Total Value
$240.04K
Shares Held After
90,180
% of Holdings
18.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
200,000
Price
$35.45
Total Value
$7.09M
Shares Held After
1,748,403
% of Holdings
10.3%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Edwards Lifesciences Corp (EW)
Lippis Daniel J. — CVP, TAVR
Shares
619
Price
$91.40
Total Value
$56.58K
Shares Held After
40,411
% of Holdings
1.5%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
17,000
Price
$26.82
Total Value
$455.90K
Shares Held After
614,321
% of Holdings
2.7%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
58,000
Price
$25.94
Total Value
$1.50M
Shares Held After
631,321
% of Holdings
8.4%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
7,400
Price
$3.03
Total Value
$22.42K
Shares Held After
98,589
% of Holdings
7.0%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
831
Price
$23.34
Total Value
$19.40K
Shares Held After
33,885
% of Holdings
2.5%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
19,608
Price
$11.04
Total Value
$216.47K
Shares Held After
213,009
% of Holdings
8.4%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
273,871
Price
$17.23
Total Value
$4.72M
Shares Held After
9,237,279
% of Holdings
2.9%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
25,836
Price
$3.44
Total Value
$88.88K
Shares Held After
71,842
% of Holdings
36.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
6,997
Price
$35.05
Total Value
$245.23K
Shares Held After
124,672
% of Holdings
5.3%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
8,300
Price
$35.05
Total Value
$290.91K
Shares Held After
58,750
% of Holdings
12.4%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
2,300
Price
$35.12
Total Value
$80.79K
Shares Held After
56,450
% of Holdings
3.9%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
6,888
Price
$35.05
Total Value
$241.45K
Shares Held After
345,879
% of Holdings
2.0%
ClearPoint Neuro, Inc. (CLPT)
BURNETT JOSEPH — Director
Shares
20,000
Price
$19.38
Total Value
$387.60K
Shares Held After
116,842
% of Holdings
14.6%
Warby Parker Inc. (WRBY)
Blumenthal Neil Harris — Director
Shares
36,300
Price
$30.04
Total Value
$1.09M
Shares Held After
59,459
% of Holdings
37.9%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
2,748
Price
$34.71
Total Value
$95.38K
Shares Held After
16,474
% of Holdings
14.3%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
15,002
Price
$34.32
Total Value
$514.87K
Shares Held After
19,222
% of Holdings
43.8%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
42,924
Price
$5.85
Total Value
$251.11K
Shares Held After
497,751
% of Holdings
7.9%
PRECIGEN, INC. (PGEN)
Sabzevari Helen — President and CEO
Shares
346,836
Price
$5.89
Total Value
$2.04M
Shares Held After
3,768,872
% of Holdings
8.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
881
Price
$192.61
Total Value
$169.69K
Shares Held After
21,656
% of Holdings
3.9%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
541
Price
$191.87
Total Value
$103.80K
Shares Held After
22,537
% of Holdings
2.3%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
600
Price
$190.54
Total Value
$114.33K
Shares Held After
23,078
% of Holdings
2.5%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
100
Price
$188.57
Total Value
$18.86K
Shares Held After
23,678
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
300
Price
$187.83
Total Value
$56.35K
Shares Held After
23,778
% of Holdings
1.2%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
858
Price
$186.92
Total Value
$160.37K
Shares Held After
24,078
% of Holdings
3.4%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
1,100
Price
$185.90
Total Value
$204.49K
Shares Held After
24,936
% of Holdings
4.2%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
900
Price
$184.59
Total Value
$166.13K
Shares Held After
26,036
% of Holdings
3.3%
Revolution Medicines, Inc. (RVMD)
Patel Sushil — Director
Shares
300
Price
$183.17
Total Value
$54.95K
Shares Held After
26,936
% of Holdings
1.1%
Showing 51–100 of 563 transactions (page 2 of 12)